FTC judge says Impax should settle
Impax Laboratories should settle the Federal Trade Commission’s allegations that it entered into a pay-for-delay agreement with Endo Pharmaceuticals, an administrative law judge suggested on Thursday.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10